title: Horizontal glottectomy: oncological results.
abstract: OBJECTIVE
  The aim of this study was to assess the oncological results of patients after horizontal glottectomy.
  
  
  METHODS
  A cohort of 35 patients (34 males and 1 female, mean age 59.2 years) who underwent a horizontal glottectomy between June 2001 and June 2010 was analysed retrospectively. The mean follow-up period was 77.9 +/- 28.1 months. The Kaplan-Meier method was used to analyse overall survival and disease-specific survival.
  
  
  RESULTS
  All of the patients were decannulated and put on a normal diet following nasogastric feeding tube removal. The overall survival rates at 3 and 5 years were 97 and 93% respectively. The 3- and 5-year disease-specific survival rates were 100 and 97% respectively. There were 2 local recurrences (5.7%), 1 distant metastasis (2.8%), and 2 second primary tumours (5.7%).
  
  
  CONCLUSIONS
  Horizontal glottectomy is an oncologically safe technique in properly selected patients with glottic tumours.
authors.affiliation: 1st Ear Nose and Throat Clinic, Istanbul Okmeydani Training and Research Hospital, Istanbul/Turkey. ilhanto@yahoo.com
authors.forename: I
authors.initials: I
authors.lastname: Topaloğlu
authors.affiliation: 1st Ear Nose and Throat Clinic, Istanbul Okmeydani Training and Research Hospital, Istanbul/Turkey.
authors.forename: Z
authors.initials: Z
authors.lastname: Saltürk
authors.affiliation: 1st Ear Nose and Throat Clinic, Istanbul Okmeydani Training and Research Hospital, Istanbul/Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Bal
authors.affiliation: Ear Nose and Throat Clinic, Yenikent Government Hospital, Sakarya, Turkey.
authors.forename: Y
authors.initials: Y
authors.lastname: Atar
mesh_terms: D000368:Aged; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D005931:Glottis / Q000601:surgery*; D006801:Humans; D015994:Incidence; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000601:surgery*; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D013997:Time Factors; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology